ANEBULO PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 90.00% for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2025-09-29
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-12-31 was 90.00%, a 50.00% increase year-over-year.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 60.00%.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-12-31 was 60.00%, a 0.00% change year-over-year.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-09-30 was 60.00%, a 20.00% increase year-over-year.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 90.00%.
- ANEBULO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 50.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2025-06-30 | 90.00% 10-K · filed 2025-09-29 | |||
| 2025-03-31 | 90.00% 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | 90.00% 10-Q · filed 2025-02-14 | 90.00% 10-Q · filed 2025-02-14 | ||
| 2024-03-31 | 60.00% 10-Q · filed 2025-05-13 | 60.00% 10-Q · filed 2025-05-13 | ||
| 2023-12-31 | 60.00% 10-Q · filed 2025-02-14 | 60.00% 10-Q · filed 2025-02-14 | ||
| 2023-09-30 | 60.00% 10-Q · filed 2024-11-13 | |||
| 2022-12-31 | 60.00% 10-Q · filed 2024-02-13 | |||
| 2022-09-30 | 50.00% 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | 50.00% 10-K · filed 2023-09-22 | |||
| 2022-03-31 | 50.00% 10-Q · filed 2023-05-11 | 50.00% 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | 50.00% 10-Q · filed 2023-02-10 | |||
| 2021-03-31 | 49.60% 10-Q · filed 2022-05-11 | 49.60% 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |